Life-years gained from coronary heart disease mortality reduction in Scotland: prevention or treatment? (Q44520744)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12873654%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Life-years gained from coronary heart disease mortality reduction in Scotland: prevention or treatment? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12873654%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

coronary artery disease

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12873654%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Belgin Ünal

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12873654%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

S Capewell

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12873654%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 June 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12873654%20AND%20SRC:MED&resulttype=core&format=json

Journal of Clinical Epidemiology

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12873654%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12873654%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12873654%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

583-590

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12873654%20AND%20SRC:MED&resulttype=core&format=json

Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900059-3

7 January 2021

Why model coronary heart disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900059-3

7 January 2021

The decline in ischemic heart disease mortality rates. An analysis of the comparative effects of medical interventions and changes in lifestyle

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900059-3

7 January 2021

Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900059-3

7 January 2021

Explanation for the decline in coronary heart disease mortality rates in Auckland, New Zealand, between 1982 and 1993

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900059-3

7 January 2021

The recent decline in mortality from coronary heart disease, 1980-1990. The effect of secular trends in risk factors and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900059-3

7 January 2021

Limitations of the Parsonnet score for measuring risk stratified mortality in the north west of England. The North West Regional Cardiac Surgery Audit Steering Group

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900059-3

7 January 2021

Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900059-3

7 January 2021

By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900059-3

7 January 2021

The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. Seven Countries Study Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900059-3

7 January 2021

Association of the California Tobacco Control Program with declines in cigarette consumption and mortality from heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900059-3

7 January 2021

Trends in case-fatality in 117 718 patients admitted with acute myocardial infarction in Scotland

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900059-3

7 January 2021

Evidence of improving prognosis in heart failure: trends in case fatality in 66 547 patients hospitalized between 1986 and 1995

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900059-3

7 January 2021

Sex differences in myocardial infarction and coronary deaths in the Scottish MONICA population of Glasgow 1985 to 1991. Presentation, diagnosis, treatment, and 28-day case fatality of 3991 events in men and 1551 events in women

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900059-3

7 January 2021

Mortality in patients of the Glasgow Blood Pressure Clinic

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900059-3

7 January 2021

Time trends in survival and readmission following coronary artery bypass grafting in Scotland, 1981-96: retrospective observational study.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900059-3

7 January 2021

Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900059-3

7 January 2021

Long-term prognosis of different forms of coronary heart disease: the Reykjavik Study

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900059-3

7 January 2021

The natural history of prevalent ischaemic heart disease in middle-aged men

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900059-3

7 January 2021

Expected gains in life expectancy from various coronary heart disease risk factor modifications

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900059-3

7 January 2021

How can we best prolong life? Benefits of coronary risk factor reduction in non-diabetic and diabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900059-3

7 January 2021

Economics notes: handling uncertainty in economic evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900059-3

7 January 2021

Substantial potential for reductions in coronary heart disease mortality in the UK through changes in risk factor levels

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900059-3

7 January 2021

Cost-effectiveness of the North Karelia Hypertension Program. 1972-1977

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900059-3

7 January 2021

Changes in population cholesterol levels and coronary heart disease deaths in seven countries.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900059-3

7 January 2021

Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900059-3

7 January 2021

Decline in ischaemic heart disease in Iceland and change in risk factor levels

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900059-3

7 January 2021

Relationship Between Risk Factor Trends and Disease Trends

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900059-3

7 January 2021

Relations of changes in coronary disease rates and changes in risk factor levels: methodological issues and a practical example.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900059-3

7 January 2021

Regression analysis of recent changes in cardiovascular morbidity and mortality in The Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900059-3

7 January 2021

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900059-3

7 January 2021

Measuring the costs and benefits of heart disease monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900059-3

7 January 2021

Effect of reducing ambulance response times on deaths from out of hospital cardiac arrest: cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900059-3

7 January 2021

Survey of 3765 cardiopulmonary resuscitations in British hospitals (the BRESUS Study): methods and overall results

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900059-3

7 January 2021

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900059-3

7 January 2021

ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. The ISIS-2 (Second International Study of Infarct Survival) Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900059-3

7 January 2021

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900059-3

7 January 2021

Cumulative meta-analysis of therapeutic trials for myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900059-3

7 January 2021

Prevention of suboptimal beta-blocker treatment in patients with myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900059-3

7 January 2021

ACE inhibitor use in patients with myocardial infarction. Summary of evidence from clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900059-3

7 January 2021

General pharmacologic treatment of acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900059-3

7 January 2021

Randomised trials of secondary prevention programmes in coronary heart disease: systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900059-3

7 January 2021

Blood-pressure reduction and cardiovascular risk in HOPE study

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900059-3

7 January 2021

Benefit of heparin plus aspirin vs aspirin alone in unstable angina

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900059-3

7 January 2021

Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900059-3

7 January 2021

A British Cardiac Society survey of the potential for the secondary prevention of coronary disease: ASPIRE (Action on Secondary Prevention through Intervention to Reduce Events).

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900059-3

7 January 2021

Blood pressure, stroke, and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900059-3

7 January 2021

Control of blood pressure in Scotland: the rule of halves

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900059-3

7 January 2021

Cardiovascular protection and blood pressure reduction: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900059-3

7 January 2021

Compliance becomes concordance

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900059-3

7 January 2021

10.1016/S0895-4356(03)00059-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12873654%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference